Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,229 | 141 | 65.7% |
| Travel and Lodging | $2,206 | 8 | 34.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,156 | 20 | $0 (2020) |
| CSL Behring | $1,130 | 6 | $0 (2018) |
| Janssen Research & Development, LLC | $942.02 | 9 | $0 (2023) |
| ABIOMED | $523.79 | 1 | $0 (2019) |
| Medtronic Vascular, Inc. | $311.61 | 3 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $292.56 | 19 | $0 (2024) |
| PFIZER INC. | $253.50 | 15 | $0 (2024) |
| Amgen Inc. | $229.96 | 14 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $205.43 | 7 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $171.97 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $326.25 | 18 | PFIZER INC. ($108.50) |
| 2023 | $1,387 | 17 | Janssen Research & Development, LLC ($942.02) |
| 2022 | $16.21 | 1 | E.R. Squibb & Sons, L.L.C. ($16.21) |
| 2021 | $42.58 | 3 | E.R. Squibb & Sons, L.L.C. ($17.54) |
| 2020 | $209.71 | 5 | Boston Scientific Corporation ($163.40) |
| 2019 | $1,632 | 32 | ABIOMED ($523.79) |
| 2018 | $1,837 | 41 | CSL Behring ($1,130) |
| 2017 | $984.02 | 32 | BOSTON SCIENTIFIC CORPORATION ($298.92) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.25 | General |
| Category: Cardiovascular | ||||||
| 08/28/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $34.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/20/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiology | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 06/19/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/29/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/03/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/19/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Cardiac Rhythm Management | ||||||
| 03/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $4.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/31/2024 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.89 | General |
| Category: Cardiovascular | ||||||
| 12/06/2023 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $171.97 | General |
| Category: Cardiovascular Device | ||||||
| 11/30/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $164.65 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/14/2023 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $249.32 | General |
| 09/14/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 09/14/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 09/14/2023 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $43.77 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 949 | 1,098 | $358,841 | $91,772 |
| 2022 | 22 | 1,138 | 1,410 | $396,369 | $105,908 |
| 2021 | 20 | 1,230 | 1,441 | $361,095 | $108,606 |
| 2020 | 22 | 1,330 | 1,706 | $253,863 | $89,526 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 294 | 418 | $144,628 | $36,252 | 25.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 48 | 48 | $36,912 | $9,099 | 24.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 14 | 16 | $24,512 | $6,636 | 27.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 48 | $23,328 | $6,530 | 28.0% |
| G0422 | Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | Office | 2023 | 65 | 67 | $21,641 | $6,500 | 30.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 120 | 120 | $22,320 | $5,814 | 26.0% |
| G0423 | Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | Office | 2023 | 48 | 48 | $15,504 | $4,714 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $16,613 | $4,193 | 25.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 42 | $7,896 | $2,678 | 33.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $9,378 | $2,506 | 26.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $8,895 | $2,492 | 28.0% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 18 | 18 | $7,668 | $1,336 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 21 | $5,145 | $960.70 | 18.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 65 | 65 | $9,230 | $646.10 | 7.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 47 | $1,833 | $510.84 | 27.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 22 | 22 | $1,474 | $419.16 | 28.4% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 23 | 23 | $1,518 | $388.20 | 25.6% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 11 | 11 | $220.00 | $62.92 | 28.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 14 | 14 | $126.00 | $34.72 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 329 | 503 | $174,038 | $47,556 | 27.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 166 | 166 | $30,876 | $8,749 | 28.3% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 16 | 19 | $28,994 | $7,699 | 26.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 36 | 36 | $27,576 | $6,794 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 37 | 45 | $21,690 | $6,340 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $20,962 | $5,016 | 23.9% |
About Dr. Joseph Burchenal, MD
Dr. Joseph Burchenal, MD is a Interventional Cardiology healthcare provider based in Littleton, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114946662.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Burchenal, MD has received a total of $6,435 in payments from pharmaceutical and medical device companies, with $326.25 received in 2024. These payments were reported across 149 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,229).
As a Medicare-enrolled provider, Burchenal has provided services to 4,647 Medicare beneficiaries, totaling 5,655 services with total Medicare billing of $395,811. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Location Littleton, CO
- Active Since 07/18/2006
- Last Updated 10/12/2012
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1114946662
Products in Payments
- Impella (Device) $523.79
- GENERAL THERAPIES (Device) $405.84
- ELIQUIS (Drug) $345.55
- CROSSBOSS (Device) $254.40
- Corlanor (Drug) $229.96
- Resolute (Device) $174.58
- OPTIMIZER (Device) $171.97
- Barostim Neo System (Device) $164.65
- BRILINTA (Drug) $161.77
- XARELTO (Drug) $160.03
- Amplia MRI (Device) $137.03
- VYNDAQEL (Drug) $134.08
- SYNERGY (Device) $125.26
- GUIDEZILLA (Device) $111.11
- BYSTOLIC (Drug) $110.71
- KENGREAL (Drug) $100.83
- ENTRESTO (Drug) $79.16
- GENERAL - STENTS (Device) $57.52
- GENERAL - STRUCTURAL HEART (Device) $53.00
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $49.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Littleton
Dr. Lee Macdonald, Md, MD
Interventional Cardiology — Payments: $60,213
Dr. Dimitri Kaufman, Md, MD
Interventional Cardiology — Payments: $556.99
Dr. Steven Friedrich, Md, MD
Interventional Cardiology — Payments: $190.21